Cargando…

NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling

BACKGROUND: Kidney Renal Clear Cell Carcinoma (KIRC) accounts for 75% of all renal cancers. Previous study had conflict evidences regarding NR1B2 role in cancer, and its expression and biological role in KIRC remained unclear. Our aims were to characterize the role of NR1B2 in KIRC. METHODS: NR1B2 e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Lei, Li, Wenjia, Wang, Guangchun, Shi, Heng, Wang, Keyi, Yang, Huan, Peng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686564/ https://www.ncbi.nlm.nih.gov/pubmed/31391070 http://dx.doi.org/10.1186/s13046-019-1344-3

Ejemplares similares

ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis
por: Yu, Gang, et al.
Publicado: (2023)

Dynamic prognostic model for kidney renal clear cell carcinoma (KIRC) patients by combining clinical and genetic information
por: Zhao, Huiling, et al.
Publicado: (2018)

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival
por: Godlewski, J., et al.
Publicado: (2018)

Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC)
por: Zhang, Yanjun, et al.
Publicado: (2021)

SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway
por: Yin, Lei, et al.
Publicado: (2020)

The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2020)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity
por: Kim, Minsuh, et al.
Publicado: (2022)

Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2022)

Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project
por: Ricketts, Christopher J., et al.
Publicado: (2014)

The TGF(β)→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1
por: Kim, Min-Kyu, et al.
Publicado: (2023)

S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway
por: Tao, Yi-Ping, et al.
Publicado: (2023)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway
por: Ye, Xiang-Yun, et al.
Publicado: (2015)

Calotropin activates YAP through downregulation of LATS1 in colorectal cancer cells
por: Zhou, Limin, et al.
Publicado: (2019)

NRP1 transduces mechanical stress inhibition via LATS1/YAP in hypertrophic scars
por: Li, Mengzhi, et al.
Publicado: (2023)

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
por: Furth, Noa, et al.
Publicado: (2018)

Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis
por: Tan, Yuqin, et al.
Publicado: (2023)

ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC
por: Zhu, Ting, et al.
Publicado: (2022)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Pharmacological Activation of YAP/TAZ by Targeting LATS1/2 Enhances Periodontal Tissue Regeneration in a Murine Model
por: Sato, Akiko, et al.
Publicado: (2023)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma
por: Liu, Ke, et al.
Publicado: (2020)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice
por: Park, Jaeoh, et al.
Publicado: (2020)

TIP-B1 promotes kidney clear cell carcinoma growth and metastasis via EGFR/AKT signaling
por: Yin, Lei, et al.
Publicado: (2019)

Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation
por: Tang, Qian, et al.
Publicado: (2021)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

Role of a novel mouse mutant of the Galnt2(tm1Lat/tm1Lat) gene in otitis media
por: Ma, Weijun, et al.
Publicado: (2023)

NR4A1 Knockdown Suppresses Seizure Activity by Regulating Surface Expression of NR2B
por: Zhang, Yanke, et al.
Publicado: (2016)

Irisin Ameliorates Intervertebral Disc Degeneration by Activating LATS/YAP/CTGF Signaling
por: Chen, Taiqiu, et al.
Publicado: (2022)

LATS1 suppresses proliferation and invasion of cervical cancer
por: Deng, Jihong, et al.
Publicado: (2017)

Corrigendum: Role of a novel mouse mutant of the Galnt2(tm1Lat/tm1Lat) gene in otitis media
por: Ma, Weijun, et al.
Publicado: (2023)

Streichquartett Nr. 1 ; Streichquartett Nr. 2
por: Ligeti, György, 1923-
Publicado: (1988)

Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
por: Kumar, Balawant, et al.
Publicado: (2021)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
por: Lodge, Emily J, et al.
Publicado: (2019)

Corrigendum: NR4A1 Knockdown Suppresses Seizure Activity by Regulating Surface Expression of NR2B
por: Zhang, Yanke, et al.
Publicado: (2017)

LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically ‘Cold’ KIRC Tumours
por: Zhang, Shichao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kr8c2lr14ogsesgq4bgj7hk63q